首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives
【2h】

Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives

机译:新型噻唑烷酮衍生物支架的合成及抗弓形虫活性的生物学评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We designed and synthesised novel N-substituted 1,3-thiazolidin-4-one derivatives for the evaluation of their anti-Toxoplasma gondii efficacy. This scaffold was functionalised both at the N1-hydrazine portion with three structurally different moieties and at the lactam nitrogen with substituted benzyl groups selected on the basis of our previous structure-activity relationships studies. Using three different assay methods, the compounds were assessed in vitro to determine both the levels of efficacy against the tachyzoites of T. gondii (IC50 = 5–148 μM), as well as any evidence of cytotoxicity towards human host cells (TD50 = 68 to ≥320 μM). Results revealed that ferrocene-based thiazolidinones can possess potent anti-tachyzoite activity (TI =2–64).
机译:我们设计和合成了新颖的N-取代的1,3-噻唑烷-4-酮衍生物,以评估其抗弓形虫的功效。根据我们先前的结构活性关系研究,该支架在具有三个结构不同部分的N1-肼部分和在具有取代苄基的内酰胺氮上都进行了功能化。使用三种不同的测定方法,对化合物进行体外评估,以确定其对弓形虫速殖子的药效水平(IC50 == 5-148µM),以及对人宿主细胞有细胞毒性的任何证据(TD50 == 68)至≥320μM)。结果表明,基于二茂铁的噻唑烷酮具有强大的抗速殖子活性(TI = 2-64)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号